E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial
Eric J. Topol,Daniel B. Mark,A. Michael Lincoff,Eric A. Cohen,Jeffrey R. Burton,Neal S. Kleiman,David Talley,Shelly Sapp,Joan E. Booth,Catherine F. Cabot,Keaven M. Anderson,Robert M. Califf +11 more
TL;DR: Coronary stenting with abciximab, compared with stenting alone or balloon angioplasty with ab ciximabs, is associated with improved survival and is an economically attractive therapy by conventional standards.
Journal ArticleDOI
Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial
Steven R. Steinhubl,Jill Waalen,Alison M. Edwards,Lauren Ariniello,Rajesh R. Mehta,Gail S. Ebner,C Carter,Katie Baca-Motes,Elise Felicione,Troy C. Sarich,Eric J. Topol +10 more
TL;DR: Among individuals at high risk for AF, immediate monitoring with a home-based wearable ECG sensor patch, compared with delayed monitoring, resulted in a higher rate of AF diagnosis after 4 months.
Journal ArticleDOI
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study
Herbert D. Aronow,Eric J. Topol,Matthew T. Roe,Penny L. Houghtaling,Katherine E. Wolski,A. Michael Lincoff,Robert A. Harrington,Robert M. Califf,E. Magnus Ohman,Neal S. Kleiman,Matyas Keltai,Robert G. Wilcox,Alec Vahanian,Paul W. Armstrong,Michael S. Lauer +14 more
TL;DR: Prescription of a lipid-lowering drug at hospital discharge was independently associated with reduced short-term mortality among patients after an acute coronary syndrome.
Journal ArticleDOI
The importance of phase information for human genomics.
Ryan Tewhey,Vikas Bansal,Vikas Bansal,Ali Torkamani,Ali Torkamani,Ali Torkamani,Eric J. Topol,Eric J. Topol,Eric J. Topol,Nicholas J. Schork,Nicholas J. Schork,Nicholas J. Schork +11 more
TL;DR: Findings indicate that relationships between human DNA sequence and phenotype, including disease, can be more fully understood with phase information, and the existing technological impediments to obtaining phase information must be overcome if human genomics is to reach its full potential.
Journal ArticleDOI
Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non–ST-Elevation Acute Coronary Syndromes Early Benefit During Medical Treatment Only, With Additional Protection During Percutaneous Coronary Intervention
Eric Boersma,K. Martijn Akkerhuis,Pierre Théroux,Robert M. Califf,Eric J. Topol,Maarten L. Simoons +5 more
TL;DR: There is conclusive evidence of an early benefit of GP IIb/IIIa inhibitors during medical treatment in patients with acute coronary syndromes without persistent ST-segment elevation and in patients subsequently undergoing PCI, GP II-IIIa inhibition protects against myocardial damage associated with the intervention.